In this issue:
Associations between IBD and mental illnesses
Induction AJM300 (carotegrast methyl) for moderately active UC
Paternal IBD medication use and hospital infection risk in offspring
Exposure-response relationship of vedolizumab in IBD
Vedolizumab vs. ustekinumab in CD after anti-TNFα failure
No increased UC flare risk after stopping 5-ASA in steroid-free remission
Corticosteroid exposure for maternal IBD and adverse perinatal outcomes
Treatment failure with vedolizumab ±thiopurines in CD
Extended tofacitinib induction for UC
Bariatric surgery in IBD patients
Please login below to download this issue (PDF)